ArticleOncoTargets and therapy2021

Complete Response to PD-1 Inhibitor in Primary Hepatocellular Carcinoma Patients Post-Progression on Bi-Specific Antibody Conjugated CIK Cell Treatment: A Report of Two Cases.

Tong Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.